Canada markets close in 1 hour 19 minutes

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7244+0.0185 (+2.62%)
As of 02:38PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 76.46M
Enterprise Value 78.19M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)16.88
Price/Book (mrq)7.16
Enterprise Value/Revenue 23.44
Enterprise Value/EBITDA -1.23

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 3-75.57%
S&P500 52-Week Change 327.61%
52 Week High 33.7700
52 Week Low 30.5400
50-Day Moving Average 30.7697
200-Day Moving Average 31.3547

Share Statistics

Avg Vol (3 month) 32.09M
Avg Vol (10 day) 32.84M
Shares Outstanding 5121.4M
Implied Shares Outstanding 6N/A
Float 898.53M
% Held by Insiders 11.04%
% Held by Institutions 134.60%
Shares Short (Nov. 14, 2021) 41.44M
Short Ratio (Nov. 14, 2021) 40.59
Short % of Float (Nov. 14, 2021) 41.39%
Short % of Shares Outstanding (Nov. 14, 2021) 41.19%
Shares Short (prior month Oct. 14, 2021) 41.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,960.07%

Management Effectiveness

Return on Assets (ttm)-64.82%
Return on Equity (ttm)-180.07%

Income Statement

Revenue (ttm)3.34M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)467k
EBITDA -63.61M
Net Income Avi to Common (ttm)-69.16M
Diluted EPS (ttm)-0.7740
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.73M
Total Cash Per Share (mrq)0.12
Total Debt (mrq)16.47M
Total Debt/Equity (mrq)154.22
Current Ratio (mrq)2.27
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-65.93M
Levered Free Cash Flow (ttm)-41.82M